Premium-based site launches on October 18th during the BIO Investor Forum;
BIO is BioWeekSF’s inaugural “Welcome” Partner
SAN FRANCISCO, Sept. 28, 2017 -- Big3Bio, the leading aggregator service for the top three life sciences hubs in the US—Boston, San Francisco Bay Area, and San Diego—proudly announces the upcoming launch of BioWeekSF (BioWeekSF.com), a premium website dedicated to optimizing the experience of attendees for the week of the J.P. Morgan Healthcare Conference in San Francisco, January 7-12, 2018 (“JPM Week”).
BioWeekSF is a valuable, must-have resource for JPM Week attendees, providing exclusive discounts, important news and updates, a portal to all events, customized consulting services, and more for this gathering of more than 40,000 investors, company executives, analysts, bankers, journalists, and other interested parties.
“Last year, our ‘On Your Mark: 2017’ guide for JPM Week was very well received, and our most downloaded publication,” says Tilton Little, publisher of Big3Bio. “This year we are building on that success with BioWeekSF, the ultimate resource for JPM Week participants.”
Big3Bio is also proud to announce that the Biotechnology Innovation Organization (BIO) has signed on as BioWeekSF’s inaugural “Welcome” Partner. To benefit the biotech community, BIO is offering complimentary access to the BIO One-on-One Partnering™ system during JPM Week to make it easier and more affordable to partner in downtown San Francisco.
“BIO One-on-One Partnering will allow you to request and schedule meetings with biotechs, investors, in-licensors, and others, saving you time and energy coordinating meetings during the jam-packed JPM Week,“ says Willie Reaves, director of Partnering Products & Services at BIO. “We look forward to working with Big3Bio to provide this free resource to BioWeekSF members.”
BioWeekSF will launch on October 18th during the BIO Investor Forum in San Francisco, along with an invite-only reception. The site will run from October 18 through JPM Week at a rate of $99 per individual membership. As a special part of its premium content, BioWeekSF will offer access to all types of experts who can answer specific questions and guide both sides of the partnering and fundraising table.
“Attending JPM Week is a must for almost everyone in the business of biopharma and healthcare,” says Little. “They go to sow the seeds of potential partnerships, seek investors, or just to create visibility in an increasingly crowded space. BioWeekSF will make sense out of this chaos and deliver a great overall value for attendees during this crucial week.”
BioWeekSF, BIO, and BIO’s provision of the BIO One-on-One Partnering™ system are not affiliated with J.P. Morgan or the J.P. Morgan Healthcare Conference.
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
About Big3Bio
Big3Bio is the leading aggregator service for the top three life science hubs in the world: Boston, San Diego, and the San Francisco Bay Area. Big3Bio’s newsletters and additional channels provide complete, daily coverage of the news, events, jobs, and developments in these regions to the industry’s top professionals and executives. More information is available at www.bigcom.bio. Subscribe to the Big3Bio newsletters at www.big3bio.com.
Contact: Robert Slocumb [email protected]


California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



